comparemela.com
Home
Live Updates
Scib1 - Breaking News
Pages:
Latest Breaking News On - Scib1 - Page 1 : comparemela.com
SCIB1 Plus Nivolumab/Ipilimumab Generates ORR of 85% in Advanced Unresectable Melanoma
SCIB1 plus nivolumab and ipilimumab elicited responses in patients with advanced, unresectable melanoma.
United kingdom
Lindy durrant
University of nottingham
Academic department of clinical oncology
Academic department
Clinical oncology
vimarsana © 2020. All Rights Reserved.